Maximo F. Nougues, Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 9,386 shares at $8.26 ($78K) on 2026-07-06, disclosed to the SEC on 2026-07-08.
Scheduled sale ($78k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2025-01-03 | $32K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $15K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $17K | — | Filing → |